These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Altered functions of platelets during aging. Montenont E; Rondina MT; Campbell RA Curr Opin Hematol; 2019 Sep; 26(5):336-342. PubMed ID: 31348047 [TBL] [Abstract][Full Text] [Related]
4. Thrombotic and cardiovascular risks in type two diabetes; Role of platelet hyperactivity. Gaiz A; Mosawy S; Colson N; Singh I Biomed Pharmacother; 2017 Oct; 94():679-686. PubMed ID: 28787703 [TBL] [Abstract][Full Text] [Related]
5. Platelet-Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches. Gauer JS; Ajjan RA; Ariëns RAS J Am Heart Assoc; 2022 Oct; 11(20):e027071. PubMed ID: 36250653 [TBL] [Abstract][Full Text] [Related]
6. Platelet dysfunction in vascular pathologies and how can it be treated. Alexandru N; Popov D; Georgescu A Thromb Res; 2012 Feb; 129(2):116-26. PubMed ID: 22035630 [TBL] [Abstract][Full Text] [Related]
7. Platelet in thrombo-inflammation: Unraveling new therapeutic targets. Sharma S; Tyagi T; Antoniak S Front Immunol; 2022; 13():1039843. PubMed ID: 36451834 [TBL] [Abstract][Full Text] [Related]
8. Modulators of platelet function in aging. Iyer KS; Dayal S Platelets; 2020 May; 31(4):474-482. PubMed ID: 31524038 [TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Kaur R; Kaur M; Singh J Cardiovasc Diabetol; 2018 Aug; 17(1):121. PubMed ID: 30170601 [TBL] [Abstract][Full Text] [Related]
10. Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms. Marin Oyarzún CP; Heller PG Front Immunol; 2019; 10():1373. PubMed ID: 31258539 [TBL] [Abstract][Full Text] [Related]
11. The role of circulating platelet transcripts. Clancy L; Freedman JE J Thromb Haemost; 2015 Jun; 13 Suppl 1():S33-9. PubMed ID: 26149043 [TBL] [Abstract][Full Text] [Related]
12. Molecular Drivers of Platelet Activation: Unraveling Novel Targets for Anti-Thrombotic and Anti-Thrombo-Inflammatory Therapy. Chatterjee M; Ehrenberg A; Toska LM; Metz LM; Klier M; Krueger I; Reusswig F; Elvers M Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114406 [TBL] [Abstract][Full Text] [Related]
13. Platelets in Thrombo-Inflammation: Concepts, Mechanisms, and Therapeutic Strategies for Ischemic Stroke. Burkard P; Vögtle T; Nieswandt B Hamostaseologie; 2020 Jun; 40(2):153-164. PubMed ID: 32455457 [TBL] [Abstract][Full Text] [Related]
15. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Xu XR; Zhang D; Oswald BE; Carrim N; Wang X; Hou Y; Zhang Q; Lavalle C; McKeown T; Marshall AH; Ni H Crit Rev Clin Lab Sci; 2016 Dec; 53(6):409-30. PubMed ID: 27282765 [TBL] [Abstract][Full Text] [Related]
16. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Fuentes Q E; Fuentes Q F; Andrés V; Pello OM; Font de Mora J; Palomo G I Platelets; 2013; 24(4):255-62. PubMed ID: 22671308 [TBL] [Abstract][Full Text] [Related]
17. Platelets as Mediators of Neuroinflammation and Thrombosis. Rawish E; Nording H; Münte T; Langer HF Front Immunol; 2020; 11():548631. PubMed ID: 33123127 [TBL] [Abstract][Full Text] [Related]
18. Oxidised Low-Density Lipoprotein-Induced Platelet Hyperactivity-Receptors and Signalling Mechanisms. Berger M; Naseem KM Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012465 [TBL] [Abstract][Full Text] [Related]
19. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles. Petrides PE; Siegel F Blood Cells Mol Dis; 2006; 36(3):379-84. PubMed ID: 16563815 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory Contribution of Platelets Revisited: New Players in the Arena of Inflammation. Chatterjee M; Geisler T Semin Thromb Hemost; 2016 Apr; 42(3):205-14. PubMed ID: 26886394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]